CSAG1 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-69065
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to amino acids: PLSNNHPSTPKRRGRGKHPLIPGPEALSKF
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for CSAG1 Antibody
Immunocytochemistry/ Immunofluorescence: CSAG1 Antibody [NBP2-69065]
Immunocytochemistry/Immunofluorescence: CSAG1 Antibody [NBP2-69065] - Staining of human cell line SK-MEL-30 shows localization to vesicles.Applications for CSAG1 Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
Recommended conditions: Fixation/Permeabilization: PFA/Triton X-100
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CSAG1
Alternate Names
Cancer/testis antigen 24.1, Cancer/testis antigen CSAGE, chondrosarcoma associated gene 1, CSAGEcancer/testis antigen family 24, member 1, CT24.1putative chondrosarcoma-associated gene 1 protein
Gene Symbol
CSAG1
Additional CSAG1 Products
Product Documents for CSAG1 Antibody
Product Specific Notices for CSAG1 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...